Applications of MDMA in Modern Medicine - A Literature Review
Wiktoria Podlasiewicz, Paweł Siudziński, Mateusz Łyko, Alicja Skoczylas, Jakub Kurasz, Wojciech Maj, Wiktoria Tomaszewska, Katarzyna Pala, Piotr Dudziak, Anna Nowak, Maria Golińska
Journal of Education, Health and Sport January 14, 2025 DOI: 10.12775/jehs.2025.77.56620 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | MDMA |
| Keywords | Traditional medicine Pharmacology |
| Key findings | MDMA-assisted psychotherapy offers significant therapeutic benefits for PTSD and anxiety disorders, with emerging evidence for depression and eating disorders. |
Abstract
MDMA or 3,4- methylenedioxymethamphetamine is a psychoactive substance, exhibiting mild hallucinogenic properties, that became widely known as a recreational party drug. However, its ability in helping individuals access deeply rooted emotions has prompted significant interest in its potential applications within clinical practice. MDMA’s mechanism of action involves increasing the release of serotonin, dopamine and oxytocin. This process enhances neuroplasticity, fosters empathy and aids in trauma processing and fear extinction. This study aims to explore the potential uses of MDMA in medicine, particularly in treating mental illnesses. The article was developed using data from the „PubMed” and „Google Scholar” databases, with particular emphasis on articles published after 2021. When combined with psychotherapy, MDMA offers significant therapeutic benefits, especially for patients resistant to conventional treatments. Existing research primarily highlights its effectiveness in managing post traumatic stress disorder (PTSD) and anxiety disorders, with emerging evidence suggesting potential benefits for conditions like depression and eating disorder. While recreational use of MDMA poses risks, its use in a controlled environment demonstrates a favourable safety profile. Despite the highly promising results of MDMA- assisted therapy so far, additional clinical research is crucial to enable this drug to revolutionise future treatment methods.
Comparable studies
Other narrative reviews on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Human Pharmacology of MDMA | 2004 | Review | |
| Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research | 2001 | Review | |
| 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans | 1994 | Review | |
| (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals | 2000 | Review | |
| Amphetamine toxicities | 2010 | Review |
Citations in the library
Cites 28
- 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry May 1, 2018
- MDMA enhances emotional empathy and prosocial behavior Social Cognitive and Affective Neuroscience October 4, 2013
- Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology November 1, 2018
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine Journal of Neuroscience November 30, 2020
- 3,4-methylenedioxymethamphetamine (MDMA): current perspectives Substance Abuse and Rehabilitation November 1, 2013
and 23 more in the library